cervical cancer

BD wins FDA approval for cervical cancer screening self-collection kit
Medtech Dive
Fri, 05/17/24 - 11:09 am
BD Medical
Medtech
diagnostics
FDA
HPV
cervical cancer
FDA grants full approval for Pfizer's cervical cancer drug
Reuters
Mon, 04/29/24 - 11:01 pm
Pfizer
cervical cancer
FDA
Tivdak
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data
BioSpace
Fri, 03/15/24 - 11:28 am
Merck
Keytruda
cervical cancer
clinical trials
HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14
Stat
Thu, 01/25/24 - 08:58 pm
HPV
vaccines
cervical cancer
Cervarix
Gardasil
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Yahoo/Zacks.com
Tue, 01/16/24 - 09:46 am
Merck
cervical cancer
Keytruda
FDA
5 Cancer Vaccines to Watch in 2024
BioSpace
Mon, 11/20/23 - 10:15 am
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
ESMO: Seagen and Genmab's Tivdak keeps cervical cancer patients alive longer
Fierce Pharma
Sun, 10/22/23 - 06:11 pm
ESMO
Pfizer
Seagen
cervical cancer
antibody-drug conjugate
Cervical cancer could be diagnosed earlier with new DNA biosensor
Biopharma Reporter
Fri, 10/6/23 - 11:41 am
cervical cancer
DNA
diagnostics
DNA biosensors
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Merck
Keytruda
FDA
cervical cancer
priority review
Genmab and Seagen’s TIVDAK trial meets primary endpoint
Clinical Trials Arena
Tue, 09/5/23 - 11:24 am
Genmab
Seagen
Tivdak
clinical trials
cervical cancer
Phase III Data Show Keytruda’s Promise in Earlier-Stage Cervical Cancer
BioSpace
Wed, 07/19/23 - 10:21 am
Merck
Keytruda
clinical trials
cervical cancer
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
Nykode collaborates with Roche for an upcoming trial in cervical cancer
Clinical Trials Arena
Thu, 06/1/23 - 11:24 am
Nykode Therapeutics
Roche
cervical cancer
VB10.16
clinical trials
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Fierce Pharma
Thu, 05/25/23 - 08:37 pm
ASCO 2023
Merck
Keytruda
cervical cancer
Nykode vaccine shows its worth in cervical cancer trial
Pharmaforum
Mon, 05/9/22 - 11:20 pm
Nykode Therapeutics
vaccines
cervical cancer
VB10.16
AstraZeneca's Imfinzi Fails to Boost Survival in Cervical Cancer
BioSpace
Thu, 03/24/22 - 11:44 am
AstraZeneca
Imfinizi
cervical cancer
clinical trials
Regeneron and Sanofi pull Libtayo app in cervical cancer, citing post-market study disagreement with FDA
Endpoints
Sun, 01/30/22 - 11:42 am
Sanofi
Regeneron
Libtayo
cervical cancer
post-marketing studies
Immuno-oncology spotlight falls on cervical cancer
EP Vantage
Tue, 12/7/21 - 10:39 am
immuno-oncology
cervical cancer
Opdivo
Keytruda
Bristol Myers Squibb
Merck
HPV vaccines reduce cervical cancer by 87%: study
Biopharma Reporter
Thu, 11/4/21 - 10:50 am
HPV
vaccines
cervical cancer
RWE

Pages